Lademann; Anne-Marie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lademann; Anne-Marie.The latest application filed is for "tacrolimus for improved treatment of transplant patients".
- Lademann; Anne-Marie - Klamperborg DK
- Lademann; Anne-Marie - Klampenborg DK
- Lademann; Anne-Marie - Gentofte DK
- - Charlottenlund DK
- Lademann; Anne-Marie - Charlottenlund N/A DK
- Lademann, Anne-Marie - Charlottelund DK
| Patent | Date |
|---|---|
| Tacrolimus For Improved Treatment Of Transplant Patients App 20220193046 - Gordon; Robert D ; et al. | 2022-06-23 |
| Tacrolimus for improved treatment of transplant patients Grant 11,123,331 - Gordon , et al. September 21, 2 | 2021-09-21 |
| Tacrolimus for improved treatment of transplant patients Grant 11,110,081 - Gordon , et al. September 7, 2 | 2021-09-07 |
| Tacrolimus For Improved Treatment Of Transplant Patients App 20210046055 - GORDON; Robert D. ; et al. | 2021-02-18 |
| Tacrolimus For Improved Treatment Of Transplant Patients App 20210046054 - GORDON; Robert D. ; et al. | 2021-02-18 |
| Tacrolimus for improved treatment of transplant patients Grant 10,864,199 - Gordon , et al. December 15, 2 | 2020-12-15 |
| Polymer release system Grant 9,694,080 - Fischer , et al. July 4, 2 | 2017-07-04 |
| Tacrolimus For Improved Treatment Of Transplant Patients App 20160243091 - GORDON; Robert D. ; et al. | 2016-08-25 |
| Tacrolimus For Improved Treatment Of Transplant Patients App 20140179731 - Gordon; Robert D. ; et al. | 2014-06-26 |
| Polymer Release System App 20140120164 - Fischer; Gina ; et al. | 2014-05-01 |
| Tacrolimus for improved treatment of transplant patients Grant 8,685,998 - Gordon , et al. April 1, 2 | 2014-04-01 |
| Tacrolimus for improved treatment of transplant patients Grant 8,664,239 - Gordon , et al. March 4, 2 | 2014-03-04 |
| Polymer release system Grant 08617605 - | 2013-12-31 |
| Polymer release system Grant 8,617,605 - Fischer , et al. December 31, 2 | 2013-12-31 |
| Controlled release carvedilol compositions Grant 8,449,914 - Andersen , et al. May 28, 2 | 2013-05-28 |
| Tacrolimus For Improved Treatment Of Transplant Patients App 20120029009 - Gordon; Robert D. ; et al. | 2012-02-02 |
| Tacrolimus For Improved Treatment Of Transplant Patients App 20110275659 - GORDON; Robert D. ; et al. | 2011-11-10 |
| Matrix Compositions For Controlled Delivery Of Drug Substances App 20100166866 - Fischer; Gina ; et al. | 2010-07-01 |
| Tacrolimus For Improved Treatment Of Transplant Patients App 20100105717 - Gordon; Robert D. ; et al. | 2010-04-29 |
| Controlled release carvedilol compositions App 20080268057 - Andersen; Christine ; et al. | 2008-10-30 |
| Polymer release system App 20080254122 - Fischer; Gina ; et al. | 2008-10-16 |
| Controlled release solid dispersions App 20080234352 - Fischer; Gina ; et al. | 2008-09-25 |
| Matrix compositions for controlled delivery of drug substances App 20070042044 - Fischer; Gina ; et al. | 2007-02-22 |
| Controlled release solid dispersions App 20050019399 - Fischer, Gina ; et al. | 2005-01-27 |
| Polymer release system App 20040234602 - Fischer, Gina ; et al. | 2004-11-25 |
| Controlled release carvedilol compositions App 20040151772 - Andersen, Christine ; et al. | 2004-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 